Clinical evaluation of the effect of cÅ«ttira apaiyÄ?ti lÄ?kiyam for the management of anaemia

Clinical evaluation of the effect of CUTTIRA APAYATI LEKIYAM for the management of PANDU NOI

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019737

Enrollment

Registered

2019-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50- Iron deficiency anemia

Interventions

Intervention1: cÅ«ttira apaiyÄ?ti lÄ?kiyam: should be administered orally twice a day after food along with kaá¹ukkÄ?y kuá¹inÄ«r Dosage: 2.5gms Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: subjects with any of the following symptoms will be included in the study 1. HB level between 7-10gms 2. Pallor of skin,tongue,mucous membrane,conjuctiva and nail buds 3. Fatigue 4. Anorexia 5. Worm infestation 6. Lack of concentration

Exclusion criteria

Exclusion criteria: subjects with 1. Hb level less than 7gm 2. Disease which required immediate medical attention such as congestive cardiac failure,renal failure,systemic illness will be excluded from the study

Design outcomes

Primary

Measure	Time frame
Relief in the symptoms of pallor of skin,tongue,mucous membrane,conjunctiva and nail buds Fatigue Anorexia Palpitation Lack of concentration worm infestation Timepoint: 20days	—

Secondary

Measure	Time frame
Improvement in HB gm%Timepoint: 28days	—

Countries

India

Contacts

Public ContactD K Soundararajan

Government Siddha Medical College and Hospital Palayamkottai

dr.dks.2012@gmail.com9442048801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026